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Table 2. Capsular titers of unabsorbed and reciprocally absorbed type 6C
rabbit antisera to types 6A, 6B and 6C
Capsular titers
Antisera 6A 6B 6C
Unabsorbed 64× 32× 64×
Absorbed by 6A – – 8×
Absorbed by 6B 16× – 16×
Absorbed by 6A with 6B – – 8×
tiserum before immunized by serotype 6C Pneumococcal. The
capsular titres of immune sera with 6A, 6B and 6C were 64×,
32× and 64×, respectively. After absorbed by 6A, 6B and 6A with
6B, the capsular titres were Neg, Neg, 8×; 16×, Neg, 16×; Neg,
Neg, 8×, respectively.
Conclusions: Prepare the serotype 6C diagnostic streptococ-
cus pneumoniae antiserum successfully, and it can be used for
serotype study.
Acknowledge: We thanks Uffe B.Skov Sørensen who came from
denmark and Nahm MH who came from USA for helps and
directions.
PP-040 Amniotic ﬂuid biochemical and immunological
parameters of pregnant women with
cytomegalovirus infection
Galyna Gaidai *,1, Larysa Bondarenko2. 1O.O.Bogomoletz
National Medical University, Kiev, Ukraine; 2SI Institute of
Pharmacology and Toxicology Academy of Medical Science of
Ukraine, Kiev, Ukraine
Cytomegaloviruses penetrate placentas and cause fetal congen-
ital defects. 1/3 of newborns with this infection dies. The rest
have intellect development delays, hearing and speech defects,
great changes in neurologic status.
Aim: This investigation was to create complex of biochemical
and immunological parameters for amniotic ﬂuid investigation
with the highest prognostic value concerning cytomegalovirus
infection.
Materials and methods: Amniotic ﬂuid was obtained via trans-
abdominal amniocentesis from 24 pregnant women with high
probability of cytomegalovirus infection (according to ultrasonic
markers). Antibidies IgM and IgG were determined by immunoen-
zymatic analysis. Biochemical parameters were investigated on
biochemical analyzer “Cobas-Mira” (Austria).
Results: In ﬁrst group (10 women with gestation terms 16-20
weeks) there were no positive results as to cytomegalovirus IgG-
antibidies. Only biochemical indices demonstrate changes: levels
of glucose and AST were increased with simultaneous decrease
of ALT activity. In second group (14 women with gestation terms
21-24 weeks) there were 2 positive results as to cytomegalovirus
IgG-antibidies. Biochemical changes became more profound:
bilirubin, total protein, glucose and AST were increased, ALT
activity- decreased 2-4 times in comparison with norm. Complex
analysis of our results in comparison with ultrasonic markers and
virological analysis demonstrate ineffectiveness of isolated use of
immunologic or ultrasonic investigations without biochemical pa-
rameters determination (especially on early terms of gestation).
PP-041 Hepatoprotective potential of root extracts of
Elephantopus scaber L on D-galactosamine/
lipopolysaccharide induced hepatitis in rats
K.S. Nataraj*,1, K. Srinivasa Reddy2, Kumar Prashanth3,
B.M. Vrushabendra Swamy3. 1SRR College of Pharmacy,
Valbhapur, Elkathurti, Kareem Nagar (Dist); 2Vaghdevi College
of Pharmacy, Hanamakonda, Warangal (Dist); 3Srinivasa
Institute of Pharmaceutical Sciences, Proddatur, Kadapa (Dist),
Andhra Pradesh, India
Background: Methanolic extract of Elephantopus scaber L.
(MEES) was evaluated for its hepatoprotective potential against
D-Galactosamine/Lipopolysaccharide (D-GalN/LPS) induced hep-
atitis in rats.
Methods: Rats were given a single intraperitoneal injection of
D-GalN/LPS (300 mg/kg body weight and 30 μg/kg body weight)
to induce liver damage. MEES was administered to rats (200, 400
and 600 mg/kg body weight for 6 days) 18 h before D-GalN/LPS
challenge.
Results: D-GalN/LPS intoxication resulted in liver injury as indi-
cated by the signiﬁcant increase (p< 0.05) in the serum activities
of marker enzymes such as aspartate amino transferase, alanine
aminotransferase, alkaline phosphatase, lactate dehydrogenase
and γ-glutamyl transpeptidase. Further, there was a signiﬁcant
increase (p < 0.05) in the levels of cholesterol, triglycerides and
free fatty acids followed by a decrease in the levels of phospho-
lipids in serum and liver in dose dependent manner. Pretreatment
with MEES reversed these alterations to near normal.
Conclusion: Results of this study revealed that MEES could afford
a signiﬁcant protection in the alleviation of D-GalN/LPS induced
hepatocellular injury.
PP-042 Blood culture; a signiﬁcant tool to reduce
mortality among surgical patients
Tabish Hussain*,1,2, Abbas Hayat2. 1Union Hospital, Tongji
Medical College, Huazhong University of Sciences and
Technology, Wuhan, China; 2Rawalpindi General Hospital,
Rawalpindi, Pakistan
Background: To study how often bacteremia is diagnosed on
blood culture and whether a positive blood culture in surgical
patients results in change of Therapy or affects the rate of
mortality.
Methods: 25 high-risk surgical patients with fever, leucocytosis
and other septic parameters were studied at Rawalpindi General
hospital,Rawalpindi,Pakistan from April 2007 to April 2008. Blood
cultures were taken and growth reported at 48 and 120 hours
for aerobes and anaerobes. On average, three blood cultures per
patient were obtained during hospital stay. The decision to alter
or persist with the same antibiotic as well as further investigation
or surgical exploration was made after analyzing blood culture
data.
Results: Of 25 patients, 7 had positive blood cultures. Most posi-
tive cultures were obtained in the second week after surgery. The
major isolate recovered was Staphylococcus epidermidis (in 43%
of positive cultures) followed by Klebsiella in 28%. Mortality was
71% in patients with positive culture whereas it was 39% in cul-
ture negative patients. Most antibiotic changes and interventions
were effected in those with positive cultures.
Conclusions: Surgical patients in a intensive care unit are at
signiﬁcant risk for infectious complications. Those with positive
cultures have a highermortality rate and require a more frequent
change in antibiotics, surgical exploration or both compared to
those in whom no organism is isolated.
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PP-043 Cardiac parameters among end stage hepatitis-B
cirrhotic patients in Pakistan
Tabish Hussain*,1,2, Li Yushu1. 1Union Hospital, Tongji Medical
College, Huazhong University of Sciences and Technology,
Wuhan, China; 2Rawalpindi General Hospital, Rawalpindi,
Pakistan
Background: To compare QTc duration and heart rate (HR)
in patients of hepatitis-B having cirrhosis and compare with
non-cirrhotic controls so as to provide baseline data for the
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formulation of an intervention to cooperate between cardiology
and gastroenterology departments of the hospital and to explore
the truths behind Hepatitis-B effecting multiorgan systems.
Methods: Cross-sectional analytical study was conducted at PIMS
Hospital, Islamabad from March 2007 to August 2008. Conﬁrmed
cirrhotic end-stage liver disease HEP-B patients were recruited.
An equal numbers of non-cirrhotics were also taken as control.
ECG was recorded and values of HR and QTc were calculated.
Comparison of increased frequency of HR and prolongation of QTc
were done using Chi-square (biostatistical) Test with signiﬁcance
level at 0.05 and using SPSS15 software. Curves of HR and QTc
were plotted for the presence of cirrhosis.
Results: 78 conﬁrmed patients of HEP-B cirrhosis of liver along
with the same number of non-cirrhotic patients as control. The
mean ± SD of QTc of cirrhotic Group was 0.438±0.015 sec and
that in non-cirrhotic group was 0.432±0.010 sec and that for HR
in cirrhotic and non cirrhotic were 78.34±12.15 and 74.98±8.03
beats/min respectively. The mean QTc and HR values were signif-
icantly more among cirrhotic as compared to non cirrhotic with
p=0.006 and p=0.043 respectively.
Conclusion: Means of both HR and QTc were signiﬁcantly higher
in cirrhotic patients as compared with non-cirrhotic controls.
The data can be used in future in making and correlating cardiac
diseases with liver problems specially hepatitis B infections.
PP-044 Study on characteristics of Th17 in
HBV-associated acute on chronic liver failure
patients and the correlation with prognosis
Fang Lin*, Jiyuan Zhang, Huifen Wang, Fusheng Wang. Beijing
302 Hospital, Beijing, PR China
Background: People’s health were threatened by hepatitis B
virus-associated acute on chronic liver failure (HBV-ACLF). No
one reported the characteristics of Th17 in HBV-ACLF patients
and the immunological markers related to prognosis of HBV-ACLF
are lack.
Methods: Th17 frequency and IL-17 levels were measured on
admission in 48 HBV-ACLF, 40 chronic hepatitis B (CHB)and 38
decompensated cirrhosis (HBV-LC) patients without bacteria or
fungus infection simultaneously, 23 heathy cases (HC) were con-
trolled. Th17 frequency, as well as the plasma concentration of
IL-17 and liver tissue in situ IL-17 expression were compared
among the four different groups. Dynamic deteciotns of Th17
frequency of 48 HBV-ACLF patients on 2, 4 and 12weeks.
Result: Th17 frequency and IL-17 concentration in peripheral
blood of HBV-ACLF patients were higher than HBV group, HBV-
LC group and the healthy control group. Intrahepatic in situ
expressions of IL-17 in ACLF group were higher than those in
CHB, HBV-LC and HC. The Th17 frequency in peripheral blood
of survival ACLF patients were signiﬁcantly lower than the non-
survival patients. The frequency of Th17 decreased gradually in
survival group, Th17 frequency of non-survival group increased.
The frequencies of Th17 changes of 2 weeks to admission were
correlated with the prognosis in HBV-ACLF patients.
Conclusion: Th17 and IL-17 expressions increase in HBV-ACLF
patients. Th17 can be served as an immunological marker of
prognosis in HBV-ACLF patients.
PP-045 Effect of combination millimeter wave irradiation
on hepatic cellular cancer patient
Jinglong Chen*. Beijing Ditan Hospital, Beijing, China
Objectives: Combination MWI (millimeter wave irradiation)
called IZL-2003 immunotherapy system irradiate marrow and
Chinese channel and point, The aim was to promote bone mar-
row cell regeneration or proliferation, and increased white blood
cell count, improve patient’s quality of life and tumor immunity
function.
Methods: there was 61 selected HCC patients, 40 cases of the
total was in treatment group, MWI and general liver aids was
administered together, 21 cases was as control group with only
general liver aids, combination MWI include constant amplitude
EHF (extremely high frequency), pulse EHF and poly-energy EHF,
Irradiation frequency was between 35GHz and 42.8 GHz.
Results:MWI increased white blood cell count and haematoglobin
level for HCC patients with lower white blood cell, P value was
0.028 and 0.017 respectively, T cell subgroup CD4+ count was
raised after MWI, when CD4+ count was below 400 cells/μl, CD4+
count was raised signiﬁcantly. Otherwise, MWI improve effec-
tively symptom, appetite, physical capacity and other quality of
life. So it raised Karnofsky score, effective rate was above 80%,
P<0.05.
Conclusion: MWI increased white blood cell and haematoglobin
level for HCC patients with lower white blood cell. It was adapt
to the patient with lower white blood cell and anaemia, and
improved immunity function and other quality of life. It will be
Cooperated with radiotherapy and chemotherapy without trauma
and side effect for patients.
PP-046 The clinical features of hepatogenous diabetes
Chunyan Jiang*. Comprehensive Department, Beijing Friendship
Hospital, Capital Medical University, Beijing, China
Objectives: To investigate the clinical features and the possible
etiology of hepatogenous diabetes.
Methods: One hundred and two cases with hepatogenous dia-
betes were retrospectively analyzed and compared with those of
primary type 2 diabetes mellitus.
Results:Only 17% of patients with hepatogenous diabetes showed
the typical diabetic symptoms such as dry mouth, polydipsia,
polyphagia, polyuria, et al. The patients with hepatogenous dia-
betes showed fasting plasma glucose (FPG) as (7.8±2.6) mmol/L
and postprandial plasma glucose (PPG) as (12.7±3.0)mmol/L.
In oral glucose tolerance test (OGTT), The patients with hep-
atogenous diabetes showed a much lower level of FPG than
that of primary type 2 diabetes mellitus (P<0.01). In insulin
and C-peptide release test, both the two groups showed a de-
layed insulin peak, but the patients with hepatogenous diabetes
showed higher insulin values at all the four periods of time than
those of primary type 2 diabetes mellitus (P<0.05). After the
treatment of diet control together with the use of insulin or
other oral drugs, most patients showed normal or near normal
levels of blood glucose. Only 5 cases had diabetic complications,
and 4 cases died of complications of underlying chronic hepatic
diseases.
Conclusion: The hepatogenous diabetes is clinically asymp-
tomatic, and is characterized by higher PPG. The insulin treat-
ment is effective for the patients with hepatogenous diabetes,
and the short-time poor prognosis is more likely to be affected
by the underlying hepatic disease. Insulin resistance may play a
central role in the etiology of the hepatogenous diabetes.
PP-047 Naloxone in the management of hepatic
encephalopathy
Ming-Hua Zheng*,1, Qian Jiang2, Ke-Qing Shi 1, Yong-Ping Chen1.
1Department of Infection and Liver Diseases, The First Afﬁliated
Hospital of Wenzhou Medical College; 2Department of Clinical
Pharmacy, West China School of Pharmacy, Sichuan University
Objectives: This study aimed to assess the effectiveness and
safety of naloxone in the management of hepatic encephalopa-
thy.
Methods: We employed the method recommended by the
Cochrane Collaboration to perform a meta-analysis of ran-
domized controlled trials of naloxone therapy for hepatic en-
cephalopathy including 17 randomized controlled trials.
